Trial Profile
Efficacy of ustekinumab as rescue treatment in patients with therapy-refractory or -intolerant ulcerative colitis: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 18 Jul 2018 New trial record
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018